FindTrial
Sign In

SBRT Compared With IMRT in Treating Patients With Painful Bone Metastases

SBRT Compared With IMRT in Treating Patients With Painful Bone Metastases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17012775
Enrollment
Unknown
Registered
2017-09-23
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone secondary malignant tumor

Interventions

IMRT:radiation
SBRT:radiation

Sponsors

Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. informed consent; 2. histological diagnosis of malignancy associated with radiological evidence of painful bone metastasis; 3. aged > 18 years; 4. anticipated remaining life of at least 12 weeks (3 months); 5. pain intensity score greater than or equal to 4 points.

Exclusion criteria

Exclusion criteria: 1. pathological diagnosis of myeloma; 2. sites of previous RT or previous radioisotope treatment; 3. pain intensity score less than or equal to 4 points.

Design outcomes

Primary

MeasureTime frame
pain intensity score;—

Countries

China

Contacts

Public ContactJie ZHOU

Huazhong University of Science and Technology Tongji Medical College

327779418@qq.com+86 15871377372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026